MedPath

A clinical trial to compare two drugs bupivacaine and ropivacaine in TAP block for pain relief after completion of surgery in patients undergoing caesarean section

Not yet recruiting
Conditions
Sequelae of complication of pregnancy, childbirth, and the puerperium,
Registration Number
CTRI/2021/09/036392
Lead Sponsor
Dr Hetal N Kanabar
Brief Summary

This study is a randomized ,double blind ,parellel group, controlled trial comparing the safety and efficacy of bupivacaine 0.25%  and ropivacaine 0.5% in transeversus abdominis plane block in 50 patients undergoing lower segment caesarean section ,will be conducted at GMERS Medical College, Junagadh. The primary outcome measures will be duration of analgesia that is from the time of giving TAP block to time of giving first rescue analgesic (when VAS Score more than or equal to 6 ). Secondary outcomes will be any local site infection or haematoma, any secondary complications of local anaesthetic agents such as cardiotoxicity or neurotoxicity.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

ASA physical status 1 or 2, patients giving valid consent, undergoing elective lower segment caesarean section under spinal anaesthesia.

Exclusion Criteria

Known allergy to local anaesthetic agents, patients who are receiving any non-steroidal antiinflammatory drugs or opioids 48 hours prior to surgery, patients with any contraindication to spinal anaesthesia, thrombocytopenia, patients requiring general anaesthesia, local infection at the site of injection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
First dose of rescue analgesic will be given when VAS Score more than or equal to 6Upto 36 hours after giving TAP block
Secondary Outcome Measures
NameTimeMethod
Local site infection or haematoma, any secondary complications of local anaesthetic agents such as cardiotoxicity or neurotoxicityUpto 36 hours after giving TAP block

Trial Locations

Locations (1)

GMERS medical college and hospital , junagadh

🇮🇳

Junagadh, GUJARAT, India

GMERS medical college and hospital , junagadh
🇮🇳Junagadh, GUJARAT, India
Dr Hetal Kanabar
Principal investigator
9909960401
kanabarhetal@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.